NHI Company Profile and Key Details

National Health Investors, Inc. last paid a dividend of 3.62 per share, this equals a trailing yield of roughly 5.15%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $152.12. This means the shares are trading below this model’s fair value.

National Health Investors, Inc. generated EPS of $3.17 over the past year. Five-year average earnings growth is -3.17%. Wall Street analysts project EPS growth of 3.87% annually over the next five years. The latest quarter delivered EPS of $1.32. The next quarter is forecast at $0.79. Next year's EPS is expected at -$8.69. Analyst sentiment is bullish. Analyst rating data shows there are 4 Strong Buy ratings, 2 Buy ratings, 4 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $90.00 to $72.00. The high target offers 15.62% upside. The low target suggests -7.5% downside. The mean target is $82.30. This offers 5.73% upside. National Health Investors, Inc. earnings surprise history is a mixed track record. The quarter that ended November 06, 2025, missed forecasts by 6.45%. The prior quarter beat by 5.17%. Over the last six quarters, Apple has recorded several small beats. These include -26.36% in August 06, 2024.

National Health Investors, Inc. (NYSE:NHI) closed at $76.81 USD, losing -$1.03 (-1.32%) from the previous close of $77.84. The stock is currently within 5% of its 52-week high $65.13 and $80.56. With a market capitalization of about $3.66 billion, National Health Investors, Inc. is classified as a mid-cap and shows lower-than-market volatility (beta ~0.69). Key stats such as the average daily volume over the past year has been around 211.38 thousand shares, volume is running light vs its 52-week average. Headquartered in Murfreesboro, TN, National Health Investors, Inc. operates in the Real Estate sector and the REIT - Healthcare Facilities industry. Led by CEO D. Eric Mendelsohn, the company employs approximately 30 people and listed since October 09, 1991. Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments.

NHI has shown mixed momentum, gaining 2.6% over the past week and -0.85% over the past quarter, though year-to-date performance is up 12.32%. Short-term trend indicators are bearishly aligned (SMA20 -0.5%, SMA50 1.6%, SMA200 4.06%). The stock’s 14-day RSI is 51.06 (neutral), while the ATR of 1.55 points to moderate volatility. The stock remains sitting in the mid-range of its 52-week band, trading -3.37% below its high and over 19.51% above its low. Average 10-day trading volume of 335.64 thousand shares is significantly above the 3-month average of 198.97 thousand, indicating heightened recent market interest.

National Health Investors, Inc. has 47.47 million shares outstanding. The public float is 43.92 million shares, elevated short interest at 4.63% of float. This equals 1.87 million shares. The short ratio is 7.72 days. Institutional investors hold 76.75% of the float. Insiders own 2.17%. ADAMS W ANDREW holds 759.78 thousand shares, ADAMS ROBERT G has 180.55 thousand shares and SWAFFORD CHARLOTTE A has 110.18 thousand shares.

National Health Investors, Inc. (NYSE:NHI) shares are up 12.32% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows National Health Investors, Inc. trading at a premium to the broader market with a P/E of 25.08. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $69.66, suggesting -10.51% downside. Our AI forecast model points to short-term weakness (-1.98% over two weeks), a medium-term rise (36.86% over three months), and a longer-term gain (11.14% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that National Health Investors, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -1.98%, with price expected at $76.30 by January 02, 2026, within a range of $75.54 to $77.17 3-Month Outlook: Projected rise of 36.86%, reaching $106.53 by March 19, 2026, with a range of $103.70 to $109.16. 1-Year Outlook: Projected gain of 11.14%, with price at $86.51 by December 18, 2026, within a range of $84.51 to $88.51.

National Health Investors, Inc. trades at a P/E ratio of 25.08, slightly below the S&P 500 average, with a price-to-sales ratio of 10.41 and a price-to-book ratio of 2.49 suggesting the stock is closer to book value. The P/FCF stands at 16.42, also above market averages.